for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Drugmaker Indivior raises 2021 forecasts after strong first-half

June 30 (Reuters) - Opioid addiction treatment maker Indivior Plc said on Wednesday 2021 revenue and profit would be now significantly above its previous outlook, after a better-than-expected performance in the first half of the year.

The drugmaker now expects full-year net revenue between $705 million and $740 million, to include growth in its injectable opioid addiction treatment, Sublocade and steady sales of its top-selling medicine, Suboxone film. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Rashmi Aich)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up